GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists

doi:10.1245/s10434-022-12151-6

Editorial

. 2022 Oct;29(11):6497-6500.

doi: 10.1245/s10434-022-12151-6. Epub 2022 Jul 15.

GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists

S V S Deo¹, Jyoti Sharma², Sunil Kumar²

Affiliations

¹ Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India. svsdeo@yahoo.co.in.
² Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India.

PMID: 35838905
DOI: 10.1245/s10434-022-12151-6

Editorial

GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists

S V S Deo et al. Ann Surg Oncol. 2022 Oct.

. 2022 Oct;29(11):6497-6500.

doi: 10.1245/s10434-022-12151-6. Epub 2022 Jul 15.

Authors

S V S Deo¹, Jyoti Sharma², Sunil Kumar²

Affiliations

¹ Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India. svsdeo@yahoo.co.in.
² Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India.

PMID: 35838905
DOI: 10.1245/s10434-022-12151-6

Abstract

Cancer is emerging as a major public health challenge globally. Recently, IARC (International Association of Research on Cancer) published global cancer burden using GLOBOCAN 2020 estimates for 36 cancers in 185 countries of the world. As per the estimates of the World Health Organization (WHO) in 2019, cancer is the first or second leading cause of death in 112 of 183 countries. The major takeaways of the GLOBOCAN 2020 report relevant to the surgical oncology community include the rising global burden of cancer, global disparity in cancer incidence and mortality in different geographic regions, and the impact of the human development index (HDI) on cancer incidence and projected global cancer burden by 2040. In this article, we discuss the implications of the GLOBOCAN report on future global cancer control strategies and the role of surgical oncologists in the fight against cancer.

PubMed Disclaimer

Cited by

Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data.
Zou Y, Yue M, Jia L, Wang Y, Chen H, Zhang A, Xia X, Liu W, Yu R, Yang S, Huang P. Zou Y, et al. BMC Cancer. 2023 Nov 25;23(1):1147. doi: 10.1186/s12885-023-11628-1. BMC Cancer. 2023. PMID: 38007418 Free PMC article.
Green Onion (Allium fistulosum): An Aromatic Vegetable Crop Esteemed for Food, Nutritional and Therapeutic Significance.
Kim SH, Yoon JB, Han J, Seo YA, Kang BH, Lee J, Ochar K. Kim SH, et al. Foods. 2023 Dec 16;12(24):4503. doi: 10.3390/foods12244503. Foods. 2023. PMID: 38137307 Free PMC article. Review.
A comprehensive review of discovery and development of drugs discovered from 2020-2022.
Shareef U, Altaf A, Ahmed M, Akhtar N, Almuhayawi MS, Al Jaouni SK, Selim S, Abdelgawad MA, Nagshabandi MK. Shareef U, et al. Saudi Pharm J. 2024 Jan;32(1):101913. doi: 10.1016/j.jsps.2023.101913. Epub 2023 Dec 10. Saudi Pharm J. 2024. PMID: 38204591 Free PMC article. Review.
Caregiver acceptance of human papillomavirus vaccine for their female children in Chileka, Blantyre, Malawi.
Bwanali AN, Liundi P, Lubanga AF, Mpinganjira SL, Gadama LA. Bwanali AN, et al. Vaccine X. 2024 Sep 18;20:100557. doi: 10.1016/j.jvacx.2024.100557. eCollection 2024 Oct. Vaccine X. 2024. PMID: 39381544 Free PMC article.
Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer.
Hong L, Hong S, Zhang X. Hong L, et al. Medicine (Baltimore). 2023 Dec 1;102(48):e36433. doi: 10.1097/MD.0000000000036433. Medicine (Baltimore). 2023. PMID: 38050242 Free PMC article.

See all "Cited by" articles

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. - DOI
1. Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–72. - DOI
1. D’Cruz AK, Vaish R. Risk-based oral cancer screening—lessons to be learnt. Nat Rev Clin Oncol. 2021;18:471–2. - DOI
1. Zhang X, Zeng Q, Cai W, Ruan W. Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health. 2021;21:894–904. - DOI
1. Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, et al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: a prospective, cluster randomised controlled trial in Mumbai. BMJ. 2021;24(372):n256. - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

[1] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. - DOI

[2] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. - DOI

[3] Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–72. - DOI

[4] Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–72. - DOI

[5] D’Cruz AK, Vaish R. Risk-based oral cancer screening—lessons to be learnt. Nat Rev Clin Oncol. 2021;18:471–2. - DOI

[6] D’Cruz AK, Vaish R. Risk-based oral cancer screening—lessons to be learnt. Nat Rev Clin Oncol. 2021;18:471–2. - DOI

[7] Zhang X, Zeng Q, Cai W, Ruan W. Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health. 2021;21:894–904. - DOI

[8] Zhang X, Zeng Q, Cai W, Ruan W. Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health. 2021;21:894–904. - DOI

[9] Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, et al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: a prospective, cluster randomised controlled trial in Mumbai. BMJ. 2021;24(372):n256. - DOI

[10] Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, et al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: a prospective, cluster randomised controlled trial in Mumbai. BMJ. 2021;24(372):n256. - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists

Affiliations

GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials